comparemela.com

Latest Breaking News On - Aexon labs - Page 1 : comparemela.com

NLS Pharmaceutics Secures Patent for Dual Orexin Receptor Agonists

The new patent application from Aexon Labs, licensed to NLS Pharmaceutics, covers dual orexin receptor agonists designed to treat narcolepsy.

NLS Pharmaceutics CEO Issues Letter to Shareholders

ZURICH, SWITZERLAND / ACCESSWIRE / December 29, 2023 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company, focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system.

NLS Pharmaceutics, Whose Narcolepsy Drug Candidate Is In Clinical Trials, Recaps 2023

In a letter to shareholders, the CEO of NLS Pharmaceutics Ltd recapped the company’s progress and pitfalls for 2023.

NLS Pharmaceutics (NLSP) CEO Issues Letter to Shareholders

NLS Pharmaceutics (NLSP) CEO Issues Letter to Shareholders
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

NLS Pharmaceutics CEO Issues Letter to Shareholders

NLS Pharmaceutics CEO Issues Letter to Shareholders
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.